Hongtong Medical: First Quarter Report for 2026
Hongtong Medical: 2025 Annual Report
Hongtong Medical: Summary of the 2025 Annual Report
Gangtong Medical: 2025 Annual Performance Forecast
Gangtong Medical (301515.SZ): Has secured project orders in African regions such as Kenya in recent years.
Gelonghui, January 22nd丨Hengtong Medical (301515.SZ) stated on the investor interaction platform that the company has secured project orders in African regions such as Kenya, Tunisia, and Djibouti in recent years.
Express News | The leading brain-computer interface companies, Sanbo Brain and Aipeng Medical, achieved a two-day consecutive 20% price increase. More than 10 listed companies responded to related business inquiries on the Interactive Easy platform.
Gangtong Medical (301515.SZ): Medical cleanroom equipment and system technology can be applied to clean processing in data centers, laboratories, and similar facilities.
Gelonghui, January 6th: Ganged Healthcare (301515.SZ) stated on the interactive platform that the company focuses on providing medical gas equipment and systems as well as medical cleanroom equipment and systems for various medical institutions. It is committed to addressing issues related to medical gas supply and infection control in healthcare settings. The company's products are mainly used in hospital wards, operating rooms, ICUs, central supply departments, various laboratories, and high-altitude oxygen dispersion systems. Its medical cleanroom equipment and system technology can also be applied to clean processing in data centers, laboratories, and similar environments.
Gangtong Medical (301515.SZ): Completed Share Repurchase Plan, Repurchasing 2.86% of Total Shares
Gelonghui, November 4th ┃ G-Comm Medical (301515.SZ) announced that as of November 3, 2025, the company had repurchased shares through its dedicated securities account for share repurchases via centralized bidding. The cumulative number of shares repurchased was 2,858,786, representing 2.86% of the company’s total share capital. The highest purchase price per share was RMB 19.68, while the lowest was RMB 16.57. The total transaction amount amounted to RMB 53,046,196.79 (excluding transaction fees). The company has completed this share repurchase plan, with the actual repurchase period spanning from December 30, 2024, to 202.
Gangtong Medical: Report for the third quarter of 2025
Gangtong Medical (301515.SZ): Cumulative repurchase of 2.86% of shares
Gelonghui, October 9th – HKT Medical (301515.SZ) announced that as of September 30, 2025, the company had repurchased shares through its dedicated securities account for stock repurchases via centralized competitive bidding. The cumulative number of shares repurchased amounted to 2,858,786, representing 2.86% of the company's total share capital. The highest transaction price per share was RMB 19.68, while the lowest was RMB 16.57, with a total transaction value of RMB 53,046,196.79 (excluding transaction fees). This share repurchase complies with relevant laws and regulations as well as the company’s established share repurchase plan.
Express News | Hong Kong Connectivity Healthcare: Jointly investing in the establishment of a fund with professional investment institutions.
Express News | Port Connect Medical: In collaboration with Chengdu Wutong Tree and others, jointly invested in the establishment of Chengdu Rongchuang Port Connect Equity Investment Fund Partnership (Limited Partnership).
Gangtong Medical: 2025 Semi-Annual Report Summary
Gangtong Medical: 2025 Semi-Annual Report
Hong Kong Tong Medical (301515.SZ): The main customers are hospitals and medical institutions, and no business relationship has yet been established with brain-machine equipment companies.
On August 18, Gelonghui reported that Hong Kong Tong Medical (301515.SZ) stated on the interactive platform that the company focuses on providing medical gas equipment and systems, as well as medical clean equipment and systems for various medical institutions, aiming to address issues related to medical gas supply and healthcare-associated infections. The company's products are primarily used in hospital wards, operating rooms, ICUs, central supply rooms, various laboratories, and high-altitude diffusion oxygen scenarios. The technology of the company's medical clean equipment and systems can be applied in clean processing for data centers, laboratories, and more. Currently, the company's clients are mainly hospitals and medical institutions, and it has not yet established business relations with brain-machine equipment companies. The company will
Hong Kong Tong Medical (301515.SZ): Granted 1.23 million restricted stocks to 80 incentive targets.
Gelonghui, July 23rd | Sichuan Gangtong Medical Devices Group Co., Ltd. (301515.SZ) announced that the conditions for the grant of restricted stocks under the '2025 Restricted Stock Incentive Plan (Draft)' have been met. According to the authorization from the company's first extraordinary Shareholders' Meeting in 2025, the Board of Directors has determined that the grant date for the 2025 Restricted Stock Incentive Plan will be July 22, 2025. The restricted stocks will be granted at a price of RMB 10.01 per share to 80 eligible incentive recipients, totaling 1,230,000 shares.
Express News | Hong Kong Tong Medical: Existing products have clear application value in the support of the basic environment for Brain-computer Interface surgeries.
Hong Kong Tong Medical (301515.SZ): Plans to launch a restricted stock incentive plan in 2025.
Gelonghui, on July 1, announced that Hong Kong Tong Medical (301515.SZ) published the draft of its 2025 restricted stock incentive plan. This incentive plan intends to grant 1.23 million shares of restricted stocks to the incentive objects, accounting for 1.23% of the company's total share capital of 100 million shares as of the announcement date of this draft. The plan will grant stocks in a one-time issuance, with no reserved rights. The grant price for the restricted stocks is set at 10.13 yuan per share. The incentive plan aims to motivate a total of 80 individuals, including executives of the company who are employed by the company (including its subsidiaries) at the time of the announcement.
Hong Kong Tong Medical (301515.SZ): Has repurchased 2.86% of shares in total.
Gelonghui, May 7丨Hong Kong Tong Medical (301515.SZ) announced that as of April 30, 2025, the company repurchased shares through a dedicated securities account for Share Buyback using centralized bidding Trade, with a cumulative repurchase of 2,858,786 shares, accounting for 2.86% of the company's total equity, with the highest Fill Price at 19.68 yuan/share and the lowest Fill Price at 16.57 yuan/share, totaling an amount of 53.0462 million yuan (excluding transaction fees).
Gangtong Healthcare: First Quarter Report 2025